364 related articles for article (PubMed ID: 29383514)
1. Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials.
Niu X; Ou-Yang G; Yan PF; Huang SL; Zhang ZT; Zhang ZH
J Neurol; 2018 Jun; 265(6):1259-1268. PubMed ID: 29383514
[TBL] [Abstract][Full Text] [Related]
2. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
[TBL] [Abstract][Full Text] [Related]
3. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL
Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471
[TBL] [Abstract][Full Text] [Related]
4. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
Fortuni F; Crimi G; Leonardi S; Angelini F; Raisaro A; Lanzarini LF; Oltrona Visconti L; Ferrario M; De Ferrari GM
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):373-381. PubMed ID: 29708911
[TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses.
Udell JA; Opotowsky AR; Khairy P; Silversides CK; Gladstone DJ; O'Gara PT; Landzberg MJ
Can J Cardiol; 2014 Oct; 30(10):1216-24. PubMed ID: 25154803
[TBL] [Abstract][Full Text] [Related]
6. Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.
Alushi B; Lauten A; Cassese S; Colleran R; Schüpke S; Rai H; Schunkert H; Meier B; Landmesser U; Kastrati A
Clin Res Cardiol; 2018 Sep; 107(9):788-798. PubMed ID: 29644412
[TBL] [Abstract][Full Text] [Related]
7. Patent foramen ovale closure for patients with cryptogenic stroke: A systematic review and comprehensive meta-analysis of 5 randomized controlled trials and 14 observational studies.
Chen X; Chen SD; Dong Y; Dong Q
CNS Neurosci Ther; 2018 Oct; 24(10):853-862. PubMed ID: 29804325
[TBL] [Abstract][Full Text] [Related]
8. Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis.
Ntaios G; Papavasileiou V; Sagris D; Makaritsis K; Vemmos K; Steiner T; Michel P
Stroke; 2018 Feb; 49(2):412-418. PubMed ID: 29335335
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials.
Riaz H; Khan MS; Schenone AL; Waheed AA; Khan AR; Krasuski RA
Am Heart J; 2018 May; 199():44-50. PubMed ID: 29754665
[TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.
Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G
Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
[TBL] [Abstract][Full Text] [Related]
12. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis.
Xu HB; Zhang H; Qin Y; Xue F; Xiong G; Yang L; Bai H; Wu J
J Neurol Sci; 2018 Jul; 390():139-149. PubMed ID: 29801875
[TBL] [Abstract][Full Text] [Related]
13. Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis.
Lattanzi S; Brigo F; Cagnetti C; Di Napoli M; Silvestrini M
Cerebrovasc Dis; 2018; 45(5-6):193-203. PubMed ID: 29649819
[TBL] [Abstract][Full Text] [Related]
14. Patent foramen ovale closure versus medical therapy after cryptogenic stroke: An updated meta-analysis of all randomized clinical trials.
Kheiri B; Abdalla A; Osman M; Ahmed S; Hassan M; Bachuwa G
Cardiol J; 2019; 26(1):47-55. PubMed ID: 29512097
[TBL] [Abstract][Full Text] [Related]
15. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A
Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
Kwong JS; Lam YY; Yu CM
Int J Cardiol; 2013 Oct; 168(4):4132-8. PubMed ID: 23890879
[TBL] [Abstract][Full Text] [Related]
17. Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
Akobeng AK; Abdelgadir I; Boudjemline Y; Hijazi ZM
Catheter Cardiovasc Interv; 2018 Jul; 92(1):165-173. PubMed ID: 29602258
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.
Palaiodimos L; Kokkinidis DG; Faillace RT; Foley TR; Dangas GD; Price MJ; Mastoris I
Cardiovasc Revasc Med; 2018; 19(7 Pt B):852-858. PubMed ID: 29576519
[TBL] [Abstract][Full Text] [Related]
19. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.
Ntaios G; Papavasileiou V; Makaritsis K; Michel P
Int J Cardiol; 2013 Oct; 169(2):101-5. PubMed ID: 24041984
[TBL] [Abstract][Full Text] [Related]
20. Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials.
Nagaraja V; Raval J; Eslick GD; Burgess D; Denniss AR
Heart Lung Circ; 2013 Nov; 22(11):903-9. PubMed ID: 24035325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
